Introduction
Respiratory syncytial [sin-SISH-uhl] virus (RSV) is a common respiratory virus that infects the lungs and respiratory tract. It's most recognised for its impact on infants and young children but can affect individuals of all ages. In most cases, RSV leads to mild symptoms, including cough, congestion, runny nose, and fever. However, it can become severe, especially in infants, older people and those with immunosuppression, leading to more serious conditions such as bronchiolitis and pneumonia.
RSV is highly contagious, spreading when a person coughs or sneezes, and also by direct contact with infected surfaces. Outbreaks typically occur in the autumn and winter months. Most children have been infected with RSV by the time they are two years old, and re-infections throughout life are common but typically less severe than the initial infection.
Despite its prevalence, there is no specific treatment for RSV infection. The development of vaccines against RSV has been a significant area of research, aiming to protect the most vulnerable populations from severe outcomes.
Common symptoms and typical course of acute RSV infection
Respiratory syncytial virus (RSV) infection usually follows a common pattern, with symptoms varying from mild to severe based on the age and well-being of the person. Here are some common indicators and a general course of the illness:1
Common symptoms of RSV
- Runny nose: This is often the first symptom and can be accompanied by nasal congestion
- Cough: The cough can range from mild to severe and is persistent
- Fever: Although not always present, fever is frequent, especially in younger children
- Wheezing: This involves a high-pitched whistling sound when breathing out and is more common in infants and young children
- Rapid breathing or difficulty in breathing: Signs of respiratory distress may include grunting, flaring nostrils, and the use of accessory muscles to breathe
- Decreased appetite: Infants and children often eat and drink less due to nasal congestion and lethargy
Typical course of RSV Infection
- Onset of symptoms: Symptoms typically begin 4 to 6 days after exposure to the virus. Here, cold-like symptoms such as a runny nose and mild cough are present2
- Progression: Symptoms can progress to more severe coughing and wheezing over several days. Fever may develop after the onset of respiratory symptoms
- Peak severity: Symptoms usually peak on days 3 to 5 and then gradually improve. In severe cases, especially in infants and those with underlying health conditions hospitalisation may be required due to respiratory distress or severe dehydration
- Recovery: The total duration of illness is typically about 1 to 2 weeks, although the cough can last longer. Most healthy children and adults recover without the need for hospitalisation. Complete recovery from wheezing and other acute symptoms generally occurs within 1 to 3 weeks
Epidemiology: Prevalence of RSV among adolescents
Respiratory syncytial virus (RSV) is highly prevalent among infants and young children, with nearly all children having been infected at least once by the age of two. However, RSV continues to affect individuals throughout their lives, including adolescents, though the infection rates and symptom severity often diminish with age.
Adolescents can be re-infected with RSV however, these re-infections are typically milder compared to those in infancy or early childhood.3 Specific data on the prevalence of RSV in adolescents is less commonly reported than for younger children as adolescents generally experience fewer and milder episodes of RSV due to more mature immune systems and previous exposures that lead to partial immunity.
Short-term effects of RSV
While respiratory syncytial virus (RSV) infections are often more severe in infants and the elderly, adolescents can still experience notable short-term effects. The impact in this age group tends to be milder compared to younger children, but it is important to recognise and manage these effects. Here are some of the common short-term effects of RSV in adolescents:
- Coughing and nasal congestion: Persistent cough that can interfere with daily activities and sleep
- Sore throat: Often associated with coughing and post-nasal drip
- Fever and malaise: These can be present but are generally not as high as in younger children
- Fatigue and weakness: General feeling of malaise and decreased energy, which can affect school performance and participation in extracurricular activities
The short-term effects of RSV in adolescents, while typically not severe, can disrupt daily life. This may culminate in missed school days, impaired academic performance and disrupted social interactions. Monitoring and supportive care, such as hydration, rest, and over-the-counter medications for symptom relief, are generally sufficient for managing these effects.4
Long-term effects of RSV
The long-term effects of Respiratory Syncytial Virus (RSV) infection in adolescents are not as extensively documented as those in infants and young children, where concerns such as recurrent wheezing and asthma are more pronounced. However, for adolescents, several potential long-term consequences can arise, particularly for those with severe infections or underlying health conditions. Here’s an overview of the possible long-term effects of RSV in this age group:
- Asthma and allergic reactions: There is some evidence suggesting that severe RSV infection can increase the risk of developing or exacerbating asthma. Adolescents who had severe RSV infections, especially those requiring hospitalisation, may have an increased risk of chronic wheezing or asthma5
- Chronic obstructive pulmonary disease (COPD) risks: While typically associated with older age groups, severe RSV in adolescents could potentially contribute to long-term changes in lung function, predisposing them to conditions like COPD later in life, especially if they have recurrent severe respiratory infections6
- Recurrent infections: Adolescents who have experienced severe RSV might be slightly more susceptible to other respiratory infections. This could be due to alterations in their immune system's response or residual lung damage
- Impact on school performance: Frequent or severe illnesses, including RSV, can lead to significant school absenteeism, which may impact academic performance and cognitive development indirectly
- Psychological stress: Dealing with recurrent or chronic health issues can also lead to increased anxiety and stress, which might affect mental health and social development
- Increased medical follow-up: Adolescents with a history of severe RSV might require more frequent medical follow-ups to monitor lung function and manage symptoms, particularly if they develop chronic respiratory conditions
While the link between RSV and long-term effects in adolescents needs further research to be definitively established, it’s clear that severe cases can have extended implications. Most adolescents, however, recover from RSV with no lasting effects, particularly those with mild to moderate symptoms. The focus often remains on monitoring those with severe infections or pre-existing conditions to mitigate potential long-term impacts effectively
Understanding the risk factors that can predispose adolescents to more severe outcomes from RSV is essential for prevention and management. Here are some key risk factors associated with severe long-term effects of RSV infection:7,8
- Underlying respiratory conditions: Adolescents with pre-existing respiratory issues such as asthma, chronic lung disease, or a history of wheezing are more susceptible to severe RSV infections and may experience more significant long-term respiratory complications
- Immunocompromised state: Conditions that weaken the immune system, such as HIV/AIDS, cancer, or immune system disorders, can make it harder for the body to fight off infections and recover fully. This can lead to more severe and prolonged illness with RSV and potentially long-lasting effects
- Exposure to tobacco smoke: Environmental factors such as exposure to tobacco smoke can exacerbate respiratory infections and are linked to more severe symptoms and complications from RSV
- Premature birth: Adolescents who were born prematurely may have underdeveloped lungs and a less mature immune system, making them more vulnerable to severe respiratory infections, including RSV
- Cardiac abnormalities: Existing heart conditions can complicate the course of an RSV infection, leading to more severe outcomes and increasing the risk of long-term health issues9
- Genetic factors: Genetic predispositions can influence an individual's susceptibility to severe RSV infections and the potential for developing chronic respiratory conditions10
- Nutritional status: Poor nutrition can weaken the immune system, making it less effective at fighting infections and increasing the risk of severe outcomes from RSV
- Crowded living conditions: Living in crowded conditions or attending crowded settings like schools or dormitories can increase exposure to RSV and other pathogens, leading to higher infection rates and the potential for severe disease
Identifying and managing these risk factors can help reduce the likelihood of severe RSV infections and minimise long-term effects. This is particularly important for adolescents with these risk factors, as timely intervention and supportive care can significantly improve outcomes.
Summary
In conclusion, while respiratory syncytial virus (RSV) is widely recognised for its acute respiratory symptoms, particularly in infants and the elderly, its potential for causing long-term effects in adolescents should not be underestimated. Although the majority of adolescents experience mild symptoms and recover without significant long-term consequences, certain factors like underlying respiratory conditions, immunocompromised states, and environmental influences such as exposure to tobacco smoke can increase the risk of severe outcomes.
These severe outcomes may include chronic respiratory issues such as asthma or reduced lung function, and potentially increased susceptibility to other infections. Given these potential risks, it is essential to focus on preventive measures such as good hygiene practices, possible immunisations (once they become widely available), and minimising exposure to known risk factors.
Moreover, early and effective management of RSV infections in adolescents, particularly those at higher risk, is crucial to prevent any possible long-term effects. Understanding the full impact of RSV, particularly in understudied populations like adolescents, calls for more research to provide better insights into the long-term consequences of the infection.
By increasing awareness and knowledge, healthcare providers can better support adolescents affected by RSV, ensuring they receive the necessary care to mitigate any lasting effects and maintain their overall health and well-being.
References
- Colosia A, Costello J, McQuarrie K, Kato K, Bertzos K. Systematic literature review of the signs and symptoms of respiratory syncytial virus. Influenza Resp Viruses [Internet]. 2023 [cited 2024 Apr 26]; 17(2):e13100. Available from: https://onlinelibrary.wiley.com/doi/10.1111/irv.13100.
- Kaler J, Hussain A, Patel K, Hernandez T, Ray S. Respiratory Syncytial Virus: A Comprehensive Review of Transmission, Pathophysiology, and Manifestation. Cureus [Internet]. 2023 [cited 2024 Apr 26]. Available from: https://www.cureus.com/articles/138103-respiratory-syncytial-virus-a-comprehensive-review-of-transmission-pathophysiology-and-manifestation.
- Juhn YJ, Wi C-I, Takahashi PY, Ryu E, King KS, Hickman JA, et al. Incidence of Respiratory Syncytial Virus Infection in Older Adults Before and During the COVID-19 Pandemic. JAMA Netw Open [Internet]. 2023 [cited 2024 Apr 26]; 6(1):e2250634. Available from: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800696.
- Barr R, Green CA, Sande CJ, Drysdale SB. Respiratory syncytial virus: diagnosis, prevention and management. Therapeutic Advances in Infection [Internet]. 2019 [cited 2024 Apr 26]; 6:204993611986579. Available from: http://journals.sagepub.com/doi/10.1177/2049936119865798.
- Jiang M-Y, Duan Y-P, Tong X-L, Huang Q-R, Jia M-M, Yang W-Z, et al. Clinical manifestations of respiratory syncytial virus infection and the risk of wheezing and recurrent wheezing illness: a systematic review and meta-analysis. World J Pediatr [Internet]. 2023 [cited 2024 Apr 26]; 19(11):1030–40. Available from: https://doi.org/10.1007/s12519-023-00743-5.
- McManus TE, Coyle PV, Kidney JC. Childhood respiratory infections and hospital admissions for COPD. Respiratory Medicine [Internet]. 2006 [cited 2024 Apr 26]; 100(3):512–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0954611105002532.
- Knudson CJ, Varga SM. The Relationship Between Respiratory Syncytial Virus and Asthma. Vet Pathol [Internet]. 2015 [cited 2024 Apr 26]; 52(1):97–106. Available from: http://journals.sagepub.com/doi/10.1177/0300985814520639.
- Weisman LE. Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions: The Pediatric Infectious Disease Journal [Internet]. 2003 [cited 2024 Apr 26]; 22(Supplement):S33–9. Available from: http://journals.lww.com/00006454-200302001-00005.
- Vartiainen P, Jukarainen S, Rhedin SA, Prinz A, Hartonen T, Vabalas A, et al. Risk factors for severe respiratory syncytial virus infection during the first year of life: development and validation of a clinical prediction model. The Lancet Digital Health [Internet]. 2023 [cited 2024 Apr 26]; 5(11):e821–30. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2589750023001759.
- Choi EH, Lee HJ, Chanock SJ. Human Genetics and Respiratory Syncytial Virus Disease: Current Findings and Future Approaches. In: Anderson LJ, Graham BS, editors. Challenges and Opportunities for Respiratory Syncytial Virus Vaccines [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2013 [cited 2024 Apr 26]; bk. 372, p. 121–37. Available from: https://link.springer.com/10.1007/978-3-642-38919-1_6.